SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2017HIV care in Yangon, Myanmar; successes, challenges and implications for policy- Dr. J. HansonView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2017Acute Shigellosis among HIV-infected people in 2015: An outbreak investigation- Dr. Y.T. ShenView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2017Identifying TB co-infection - new approaches- Charoen ChuchottawornView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2017Cost effectiveness of a screening program for Cryptococcal antigenemia among ARV naive HIV inf. patients with CD4< 100 cell/cumm in a referral HIV care center at MCross Anonymous Clinic in Bangkok, Thailand: A five-year observational cohort- Dr. S. RamaView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2017Efficacy and safety of Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir alafenamide (E/C/F/TAF) in virologically suppressed asian adults with renal impairment- Dr. B. ChinView Slideset
CHChien-Ching HungMD, PhDSlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2017The SWORD study- Chien-Ching Hung, MD, PhDView Slideset
MBMark BoydBA, BM, BS, DCTH&H, MHID, MD, FRACPSlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2017ART: are two drugs enough?- Mark Boyd, BA, BM, BS, DCTH&H, MHID, MD, FRACPView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2017Key note lecture: HIV/AIDS in the Asia Pacific: Where is the Epidemic Heading?- Chris BeyrerView Slideset
MCMartin ChooMMedScSlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2017Community Perspective- Martin Choo, MMedScView Slideset
FZFujie ZhangMD, PhDSlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2017Program implementer perspective- Fujie Zhang, MD, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2018How to do a systematic review- Matthew Law, BA (Hons), MSc, PhD & Joseph Tucker, MD, PhD, AMView Slideset
